TSX Delisting Review - Ambrilia Biopharma Inc. (AMB)

TORONTO, Jan. 31 /CNW/ - DELISTING REVIEW - Ambrilia Biopharma Inc. (the "Company") - Further to TSX Bulletin #2009-1000 dated August 6, 2009, TSX was prevented from continuing its expedited delisting review of the Company (Symbol: AMB) as a result of a stay of proceedings pursuant to the Initial Order issued on July 31, 2009 by the Superior Court of Quebec under the Companies' Creditors Arrangement Act, R.S.C. 1985, c. C-36, As Amended. TSX has determined to resume its expedited delisting review of the Company. Trading in the Company's common shares will be suspended from trading at the close of market on Tuesday February 1, 2011.  

About TMX Group  
 
TMX Group's key subsidiaries operate cash and derivative markets for multiple asset classes including equities, fixed income and energy. Toronto Stock Exchange, TSX Venture Exchange, Montreal Exchange, Natural Gas Exchange, Boston Options Exchange (BOX), Shorcan, Equicom and other TMX Group companies provide trading markets, clearing facilities, data products and other services to the global financial community. TMX Group is headquartered in Toronto with offices in Montreal, Calgary and Vancouver. For more information about TMX Group, visit our website at www.tmx.com.  
   
 
 

SOURCE TMX GROUP INC.

For further information:

Corporate Communications, TMX Group Inc., Toll Free 1-888-873-8392, info@tmx.com

Profil de l'entreprise

TMX GROUP INC.

Renseignements sur cet organisme

TSX Reviews and Suspensions

Renseignements sur cet organisme


FORFAITS PERSONNALISÉS

Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .

ADHÉSION À CNW

Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.

RENSEIGNEZ-VOUS SUR LES SERVICES DE CNW

Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.